ds-8201a
Showing 1 - 8 of 8
Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)
Completed
- Adenocarcinoma, Gastric
- Neoplasm, Breast
- DS-8201a
-
Taipei, Taiwan
- +1 more
Nov 2, 2022
Tumor Metastasis Trial in Japan, Korea, Republic of, Taiwan (DS-8201a, Ritonavir, Itraconazole)
Active, not recruiting
- Neoplasm Metastasis
- DS-8201a
- +2 more
-
Sapporo, Hokkaido, Japan
- +9 more
Mar 3, 2022
Malignant Tumor of Breast Trial in Japan (DS-8201a)
Completed
- Malignant Neoplasm of Breast
- DS-8201a
-
Yokohama, Kanagawa, Japan
- +6 more
Mar 17, 2022
Breast Tumors Trial in France (DS-8201a)
Active, not recruiting
- Breast Tumors
- DS-8201a
-
Angers, France
- +20 more
Feb 1, 2022
Tumor, Gastrointestinal Trial in Japan, Korea, Republic of (DS-8201a, Physician's Choice)
Completed
- Neoplasm, Gastrointestinal
- DS-8201a
- Physician's Choice
-
Nagoya, Aichi, Japan
- +65 more
Mar 17, 2022
HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer Trial in Worldwide (DS-8201a, T-DM1)
Recruiting
- HER2-Positive Primary Breast Cancer
- Residual Invasive Breast Cancer
- DS-8201a
- T-DM1
-
Anaheim, California
- +505 more
Feb 2, 2023